Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Cytosorbents Corporation (CTSO) had Cash Flow from Investing Activities of $-0.04M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$9.63M |
|
$-4.42M |
|
$2.58M |
|
$7.05M |
|
$12.27M |
|
$-2.64M |
|
$-1.78M |
|
$-4.42M |
|
$-4.42M |
|
$-4.42M |
|
$-4.42M |
|
$-4.42M |
|
$-4.42M |
|
$-2.64M |
|
$-1.98M |
|
62.81M |
|
62.81M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$15.74M |
|
$7.17M |
|
$22.22M |
|
$37.96M |
|
$24.02M |
|
$3.09M |
|
$14.69M |
|
$38.71M |
|
$-0.75M |
|
$-3.62M |
|
$-0.75M |
|
62.84M |
|
| Cash Flow Statement Financials | |
$-1.75M |
|
|
Cash Flow from Investing Activities |
$-0.04M |
$0.00M |
|
$7.77M |
|
$5.93M |
|
$-1.84M |
|
$0.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.66 |
|
-- |
|
-- |
|
1.32 |
|
-22.96 |
|
73.18% |
|
-27.39% |
|
-27.39% |
|
-- |
|
-45.85% |
|
-45.85% |
|
$-1.69M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.70 |
|
1.42 |
|
63.40 |
|
588.15% |
|
122.19% |
|
-11.64% |
|
-188.68% |
|
$-0.01 |
|
$-0.03 |
|
$-0.03 |
|